There is no need to advertise and I agree it would be a waste of money. But free press never hurts. If Lympro is ready to go as Gerald says it is, I would, if him, do all I can to try to get it mentioned in non scientific journals (WSJ for instance. Those talking about CNN haven't kept up with the times to know CNN is irrelevant) unless there is a reason why they don't want it known.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.